Blog
RSS FeedPosted by Michael Wonder on 12 Nov 2018
SMC - November 2018 decisions
12 November 2018 - A medicine used to treat a rare cancer which occurs predominantly in very young children has ...
Posted by Michael Wonder on 08 Oct 2018
SMC - October 2018 decisions
8 October 2018 - The SMC, which advises on newly licensed medicines for use by NHSScotland, has today published advice accepting ...
Posted by Michael Wonder on 10 Sep 2018
SMC - September 2018 decisions
10 September 2018 - The Scottish Medicines Consortium, has today published advice accepting four new medicines for use by NHSScotland. ...
Posted by Michael Wonder on 13 Aug 2018
SMC - August 2018 decisions
13 August 2018 - The SMC, which advises on newly licensed medicines for use by NHSScotland, has today published advice accepting ...
Posted by Michael Wonder on 09 Jul 2018
SMC rejects ocrelizumab (Ocrevus) for relapsing remitting MS in Scotland
9 July 2018 - The MS Trust is very disappointed that the Scottish Medicines Consortium is unable to recommend ocrelizumab as ...
Posted by Michael Wonder on 09 Jul 2018
SMC - July 2018 decisions
9 July 2018 - The SMC, which advises NHSScotland on newly licensed medicines, has today published advice accepting three new medicines. ...
Posted by Michael Wonder on 13 Jun 2018
Drug approved for leukaemia treatment
11 June 2018 - A drug that reduces the chances of relapse for people with an aggressive type of leukaemia ...
Posted by Michael Wonder on 12 Jun 2018
SMC approves funding for six new therapies on the NHS
12 June 2018 - The Scottish Medicines Consortium has approved NHS funding for six new therapies, offering patients new options ...
Posted by Michael Wonder on 11 Jun 2018
SMC - June 2018 decisions
11 June 2018 - The SMC, has today published advice accepting six new medicines for use by NHSScotland. ...
Posted by Michael Wonder on 14 May 2018
The Scottish Medicines Consortium accepts use of Kyntheum (brodalumab) for eligible patients with moderate-to-severe plaque psoriasis
11 May 2018 - The SMC has issued advice accepting brodalumab 210 mg for restricted use within NHS Scotland. ...
Posted by Michael Wonder on 07 May 2018
SMC - May 2018 decisions
7 May 2018 - The Scottish Medicines Consortium, which advises on newly licensed medicines for use by NHSScotland, has today ...
Posted by Michael Wonder on 09 Apr 2018
Five new medicines accepted by SMC for use by NHSScotland
9 April 2018 - The SMC, has today published advice accepting five new medicines for use by NHSScotland. ...
Posted by Michael Wonder on 14 Mar 2018
Breast cancer drug approved for NHS use
13 March 2018 - The use of new drugs to treat breast cancer and Hodgkin’s lymphoma has been approved, bringing Scottish ...
Posted by Michael Wonder on 13 Mar 2018
Analysis: new drug decisions and NHS spending conundrums
12 March 2018 - The latest round of drug decisions from the Scottish Medicines Consortium throws up the usual mix ...
Posted by Michael Wonder on 13 Mar 2018
SMC - March 2018 decisions
12 March 2018 - SMC accepts new medicines for breast cancer and Hodgkin’s lymphoma for use by NHSScotland ...